Lipid droplets (LDs) are endoplasmic reticulum (ER)-derived lipid storage organelles uniquely encapsulated by phospholipid monolayers. LD membrane proteins are embedded into the monolayer in a monotopic hairpin topology and are therefore likely to have requirements for their biogenesis distinct from those inserting as bitopic and polytopic proteins into phospholipid bilayers. UBXD8 belongs to a subfamily of hairpin proteins that localize to both the ER and LDs, and are initially inserted into the cytoplasmic leaflet of the ER bilayer before partitioning to the LD monolayer. The molecular machinery responsible for inserting hairpin proteins into membranes, however, is unknown. Here, we report that newly synthesized UBXD8 is post-translationally inserted into discrete ER subdomains by a mechanism requiring cytosolic PEX19 and membrane-integrated PEX3, proteins hitherto exclusively implicated in peroxisome biogenesis. Farnesylation of PEX19 uncouples ER/LD and peroxisome targeting, expanding the function of this peroxin to an ER-targeting pathway and suggesting a coordinated biogenesis of LDs and peroxisomes.
Lipid droplets (LDs) are endoplasmic reticulum (ER)-derived lipid storage organelles uniquely encapsulated by phospholipid monolayers. LD membrane proteins are embedded into the monolayer in a monotopic hairpin topology and are therefore likely to have requirements for their biogenesis distinct from those inserting as bitopic and polytopic proteins into phospholipid bilayers. UBXD8 belongs to a subfamily of hairpin proteins that localize to both the ER and LDs, and are initially inserted into the cytoplasmic leaflet of the ER bilayer before partitioning to the LD monolayer. The molecular machinery responsible for inserting hairpin proteins into membranes, however, is unknown. Here, we report that newly synthesized UBXD8 is post-translationally inserted into discrete ER subdomains by a mechanism requiring cytosolic PEX19 and membrane-integrated PEX3, proteins hitherto exclusively implicated in peroxisome biogenesis. Farnesylation of PEX19 uncouples ER/LD and peroxisome targeting, expanding the function of this peroxin to an ER-targeting pathway and suggesting a coordinated biogenesis of LDs and peroxisomes.
Phospholipid bilayer membranes that ensheath cells and the organelles within them constitute a fundamental organizing principle of cellular life. Membrane-embedded proteins serve as conduits enabling selective permeability to solutes, as receptors transmitting signals between subcellular compartments, and as anchors segregating enzymes into functionally organized networks.
Not all organelles, however, are surrounded by lipid bilayers. Lipid droplets (LDs), cytoplasmic organelles that store metabolic energy as triglycerides, are an exception to this principle of organelle architecture, as they are uniquely encapsulated by a phospholipid monolayer, which segregates their hydrophobic neutral lipid core from the aqueous cytosol 1 . As a consequence of their aliphatic interiors, LDs are unable to accommodate bi-or polytopic membrane proteins, and thus LD membrane proteins are integrated into the phospholipid monolayer monotopically through hydrophobic 'hairpin' (HP) domains and expose all soluble domains to the cytosol 2 . The prevailing model of LD biogenesis posits that local triglyceride accumulation within the ER membrane bilayer triggers the budding of a LD from the cytoplasmic leaflet 1 . Several HP proteins, including AUP1 (refs 3,4) , GPAT4 (ref. 5) , AAM-B and UBXD8 (refs 6,7) exhibit a dual steady-state localization to LDs and the ER and are first integrated into the cytoplasmic leaflet of the ER membrane before localizing to LDs. Although the HP domains of these proteins are necessary and sufficient for this dual localization, the molecular machinery by which HP proteins are directed to and inserted into ER or LD membranes is unknown.
Most secreted and transmembrane proteins are directed to the ER by signal sequences that are engaged by the signal recognition particle (SRP), which recruits ribosome-nascent chain complexes to ER-resident receptors, enabling co-translational translocation of nascent polypeptides through the Sec61 translocon 8, 9 . In contrast, carboxy-terminal tail-anchored proteins are inserted into the ER membrane by a post-translational pathway consisting of the cytosolic transmembrane-domain recognition complex 10, 11 (TRC) and the ERresident receptors WRB and CAML 12, 13 . Sequential transfer of tailanchored proteins from the initial recognition complex containing BAG6 to the membrane-embedded receptor complex is coordinated by cytosolic TRC40 (ref. 14) .
In this study, we investigated the mechanism by which UBXD8, a HP protein that partitions between the cytoplasmic leaflet of the ER and the LD monolayer 6, 7 and recruits the ATPase p97 (also known as VCP) to membranes 7 , is targeted to and inserted into the ER. Our data reveal that UBXD8 is post-translationally targeted to and inserted into the ER by a mechanism that is independent of the known SRP-or TRCdependent pathways, but instead requires the peroxisome-biogenesis factors PEX19 and PEX3.
RESULTS

Post-translational insertion of UBXD8 into ER membranes
To study the mechanisms underlying membrane insertion of HP proteins, we synthesized 35 S-labelled, epitope-tagged UBXD8 in rabbit reticulocyte lysate (RRL) in the absence or presence of ER-derived rough microsomes (RMs; Fig. 1a ). Reactions were fractionated into soluble cytosolic proteins (S), peripheral membrane proteins released by extraction with sodium carbonate (P), and carbonate-resistant, membrane-integrated proteins (M). When translation was conducted in the presence of RMs, most UBXD8 was detected in the membrane fraction (M) similar to the fractionation behaviour of an SRP-dependent signal anchor protein, invariant chain (Ii) 15 , and a tail-anchored protein, RAMP4op 10 . UBXD8 and RAMP4op were efficiently integrated into RMs when RMs were present during (co-translational) or after termination (posttranslational) of protein synthesis. In contrast, Iiop was only co-translationally integrated and glycosylated as expected for an SRP substrate (Fig. 1a) . The opsin-tag contains a consensus N-glycosylation sequon that, on ER membrane translocation, causes a shift in relative molecular mass of ∼2,000 (M r ∼ 2K), reflecting addition of a N-linked glycan. Iiop and RAMP4op were efficiently glycosylated when incubated with RMs (Fig. 1a) . However, no UBXD8 glycosylation was detected, irrespective of whether the opsin-tag was at the amino or carboxy terminus, consistent with it being inserted into RMs in its native HP topology where both termini face the cytosol. Protease treatment of RMs caused the M r 50K band corresponding to full-length UBXD8 to collapse into a single fragment with the expected size (M r ∼ 5K) of the protected HP domain (Fig. 1b, lanes 1-2) , which sedimented with membranes after re-fractionation and was digested on detergent solubilization of RMs, consistent with it being membrane-integrated (Fig. 1b, lanes  3-5) . Thus, in vitro-synthesized UBXD8 can be post-translationally integrated into RMs with the same HP topology as in ER and LD membranes.
The hydrophobic sequence in UBXD8 (amino acids 90-118) serves as a membrane HP anchor 6 that is necessary and sufficient for targeting UBXD8 to LDs in vivo 16, 17 . To assess the role of the HP domain in post-translational insertion, we deleted the hydrophobic region (UBXD8 HP ) or used a minimal UBXD8 version consisting of the HP domain plus flanking residues (UBXD8 ) and monitored membrane insertion in vitro (Fig. 1c) . No UBXD8 HP was detected in the membrane fraction after in vitro translation/translocation whereas UBXD8 54-154 was efficiently inserted into RMs under co-and posttranslational conditions. A minor fraction of UBXD8 54-154 became glycosylated (Fig. 1c) , resisted protease treatment, and was efficiently affinity captured following protease treatment irrespective of the position of the tags (Fig. 1d) . Therefore, a fraction of this minimal HP construct was fully translocated across the ER membrane in vitro. Most membrane-associated UBXD8 54-154 , however, gave rise to a proteaseresistant M r ∼ 5K fragment (Fig. 1d, lanes 2, 8) that failed to bind to N-or C-terminal affinity-capture reagents (Fig. 1d, lanes 4, 6, 10, 12 ), indicating correct UBXD8 54-154 insertion into RMs in a HP topology. Thus, the HP domain is necessary and sufficient for post-translational UBXD8 insertion into the ER membrane.
UBXD8 membrane insertion is independent of SRP and TRC40
Post-translational membrane insertion of UBXD8 could suggest employment of the TRC40-mediated ER-targeting pathway. To test this possibility, we used recombinant WRBcc, a soluble fragment of the TRC40 receptor WRB that binds to substrate-loaded TRC40, to block membrane insertion of tail-anchored proteins by competing with endogenous WRB 12 . Inclusion of excess WRBcc in our in vitro translocation assays failed to alter UBXD8 insertion efficiency into RMs, despite substantially reducing the insertion of the tail-anchored protein RAMP4op (Fig. 1e) . Therefore, ER insertion of UBXD8 is independent of the TRC40-WRB pathway.
To verify this conclusion and to assess the role of the canonical SRP pathway for UBXD8 insertion into RMs, we performed import assays using RMs that had been pre-treated with either N -ethylmaleimide or trypsin ( Fig. 1f and Supplementary Fig. 1 ). Both conditions block SRP- 18, 19 and TRC40/WRB-dependent protein insertion 10, 20 . While both treatments prevented insertion of the SRP substrate Iiop, neither interfered with UBXD8 insertion (Fig. 1f) , establishing that UBXD8 integration is independent of the SRP and TRC40 pathways and, moreover, might not require ER-integrated proteins. Indeed, in vitrosynthesized UBXD8 was present in buoyant fractions following incubation with protein-free liposomes, similar to the behaviour of cytochrome b 5 (Fig. 1g) , a protein known to insert into membranes independently of membrane-integrated proteins 21 . Association of UBXD8 with liposomes required the HP domain as UBXD8 HP was retained in dense fractions on sucrose gradient fractionation. Protease treatment of UBXD8-containing liposomes led to accumulation of a M r ∼ 5K protected fragment that bound to neither N-nor C-terminal affinity-capture reagents, indicating a correct HP topology (Fig. 1h) . Thus, UBXD8 can insert into membranes post-translationally and independently of canonical SRP-or TRC40-targeting pathways, protein-conducting channels or membrane protein receptors.
UBXD8 inserts into discrete ER subdomains
Membrane insertion of UBXD8 independently of membraneintegrated proteins raises the question of how its strict localization in cells to the ER and LDs 7 is established and/or maintained. We used immunofluorescence microscopy to determine into which membranes in vitro-synthesized UBXD8 inserts in semipermeabilized cells (Fig. 2a) . Full-length UBXD8 (sUBXD8 FL op), but not sUBXD8 HP op, was recruited to discrete subcellular foci (Fig. 2b ) that are strikingly different from the characteristic reticular distribution that endogenous UBXD8 exhibits in cells at steady state. This punctate localization was not due to a general inability of proteins to insert into reticular ER in semi-permeabilized cells, because in vitro-translated RAMP4op co-localized precisely with the ER marker calreticulin (Fig. 2c) . In contrast, UBXD8 foci did not strictly co-localize with the ER markers calreticulin (Fig. 2c) or calnexin (Fig. 2d) but exhibited a reticular pattern that closely followed the distribution of the ER (Fig. 2d and Supplementary Video 1), suggesting UBXD8 insertion into distinct ER subdomains. Indeed, immuno-electron microscopy of semi-permeabilized cells revealed labelling of sUBXD8 FL op at ER membranes and on ∼150-nm-diameter electron-dense structures continuous with ER membranes (Fig. 2e, arrows) . sUBXD8 FL op failed to co-localize with LDs (Fig. 2f,g ), indicating that newly synthesized UBXD8 preferentially inserts into ER subdomains and not mature LDs. UBXD8 still inserted into foci after treatment with the long-chain fatty acyl CoA synthetase inhibitor, triacsin C (Fig. 2h) , suggesting that neutral lipid synthesis is dispensable for recruitment of newly synthesized UBXD8 to ER subdomains. These findings suggest that, while UBXD8 can spontaneously insert into protein-free membranes 
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Top Bottom which should favour prolonged engagement with cytoplasmic proteins maintaining its insertion-competent state, and used affinity capture followed by LC-MS/MS identification of proteins that specifically bound insertion-competent UBXD8 FL but not UBXD8 HP . Two proteins, BAG6 and PEX19, were exclusively captured from UBXD8 FL pulldowns (Supplementary Table 1 ). To verify these interactions and to map the interaction sites within UBXD8, we translated UBXD8 deletion mutants in vitro and assessed the amount of PEX19 and BAG6 present in complex with UBXD8 by affinity isolation and immunoblotting (Fig. 3a) . The UBXD8 HP region was both necessary and sufficient to engage PEX19 and BAG6. As the deletion of the proline-rich sequence immediately preceding the annotated HP region (UBXD8 53-90 ) reduced binding to PEX19 and BAG6, we extended the UBXD8 HP deletion to include amino acids 53-111 for all subsequent experiments.
To test whether BAG6 and PEX19 bind to UBXD8 directly, we used chemical crosslinking to generate radiolabelled, covalent pre-insertion complex adducts of in vitro-synthesized UBXD8, which were immuno-isolated following protein denaturation (Fig. 3b) . The BAG6 antibody precipitated high-molecular-weight (M r >250K) crosslinked adducts containing UBXD8 FL (lane 4), while the PEX19 antibody captured adducts of M r ∼ 80K (lane 6). Neither antibody precipitated UBXD8 53-111 adducts. These findings confirm HPdomain-dependent interactions of UBXD8 with BAG6 and PEX19 and strongly suggest that they are direct.
To determine whether PEX19 and BAG6 bind UBXD8 in the same or in distinct complexes, we assessed their presence in affinity-isolated UBXD8 pre-insertion complexes fractionated on sucrose gradients (Fig. 3c ). UBXD8 FL forms higher molecular weight complexes compared with UBXD8 53-111 and cofractionated with BAG6 in fractions 6-10, whereas PEX19 was associated with UBXD8 FL in fractions 3-6, indicating that UBXD8 FL forms distinct complexes with PEX19 and BAG6.
UBXD8 in fractions containing PEX19 was twofold more efficiently integrated into RMs than was UBXD8 in BAG6-containing fractions (Fig. 3d) . Insertion competence correlated positively with the ratio of PEX19 to UBXD8 in individual fractions ( Fig. 3e and Supplementary Fig. 2 ), suggesting that PEX19-containing complexes facilitate insertion of newly synthesized UBXD8 into ER membranes.
PEX19 specifies the subcellular localization of UBXD8
To test whether UBXD8 is a client for PEX19-mediated protein targeting in living cells, we overexpressed PEX19 appended with a nuclear localization signal, NLS-PEX19, and monitored UBXD8 localization (Fig. 4a) . Redirection of both co-expressed sUBXD8op and endogenous UBXD8 to the nucleus demonstrates that PEX19 is sufficient to re-localize UBXD8 in cells.
To determine whether PEX19 is required for ER localization of UBXD8, we generated PEX19 −/− cell lines by genome editing ( Supplementary Fig. 3a-c) . Strikingly, endogenous UBXD8 in PEX19 −/− cells was mislocalized to mitochondria and co-localized with HSP60 (Fig. 4b,c) . UBXD8 localization to ER and LDs was restored when PEX19 was reintroduced into these cells, confirming that its mislocalization was caused by the absence of PEX19 (Supplementary Fig. 3d ). Thus, PEX19 specifies steady-state ER localization of endogenous UBXD8.
PEX19 and PEX3 cooperate in UBXD8 insertion into ER subdomains
To investigate how PEX19 targets newly synthesized UBXD8 to ER subdomains, we tested the effect of recombinant PEX3 N40, a soluble variant of the membrane-resident PEX19 receptor PEX3 (ref. 22) , which is required for membrane insertion of peroxisomal membrane proteins 23 (PMPs), on the insertion of in vitro-synthesized UBXD8 in semi-permeabilized cells. In the presence of excess PEX3 N40, but not WRBcc or MBP, sUBXD8 FL op was not inserted into ER foci but instead distributed more diffusely consistent with mitochondrial mislocalization (Fig. 5a, upper) . In contrast, RAMP4op insertion was unaffected by PEX3 N40 addition but sensitive to WRBcc (Fig. 5a, lower) . These data establish an essential role for PEX19 in specifying insertion of newly synthesized UBXD8 into ER subdomains, which we propose to be ER entry sites for newly synthesized UBXD8.
PEX3 knockdown in wild-type cells (Fig. 5b) abolished the insertion of in vitro-translated sUBXD8 FL op into foci after semipermeabilization (Fig. 5c ), indicating that PEX3 is essential for correct UBXD8 insertion. In contrast, PEX19 knockdown did not affect sUBXD8 FL op insertion (Fig. 5b,c) , most likely because of the presence of RRL-derived PEX19 bound to in vitro-translated sUBXD8 FL op (Fig. 3) . Semi-permeabilized PEX19 −/− cells, however, were not competent for inserting in vitro-translated sUBXD8 FL op into ER subdomains (Fig. 5d) , most likely because these cells are also depleted of PEX3 ( Supplementary Fig. 3b ), consistent with a PEX19 role in stabilizing PEX3 (ref. 24) . Thus, both cytosolic PEX19 and membraneintegrated PEX3 are required for correct targeting and insertion of UBXD8 into ER subdomains.
UBXD8 ER insertion sites co-localize with endogenous PEX3 but are distinct from mature peroxisomes As PEX19 and PEX3 are known to insert PMPs into peroxisomes, we investigated the spatial relationship of UBXD8 insertion sites with peroxisomes in semi-permeabilized cells. Catalase-positive peroxisomes did not co-localize with UBXD8 foci but were found in close apposition (50-250 nm) in about half of the cases (Fig. 6a-d) . This relationship between UBXD8 insertion sites and peroxisomes was confirmed with the peroxisomal membrane protein PEX14 ( Supplementary Fig. 4 ).
In contrast, most UBXD8 foci (75%) co-localized with endogenous PEX3 (Fig. 6e,f) . However, we observed two distinct co-localization phenotypes: while 44% of total UBXD8 foci co-localized with a single PEX3 focus, an additional 31% of UBXD8 foci co-localized with PEX3 and were also adjacent (50-250 nm) to an additional PEX3-positive but UBXD8-negative focus. PEX3 resides in peroxisomes and the ER [25] [26] [27] [28] . As UBXD8 insertion sites are positive for PEX3 but negative for catalase, our data suggest that UBXD8 is specifically inserted into PEX3-containing sites that are not peroxisomes, potentially corresponding to pre-peroxisomal ER 29 . To assess the role of mature peroxisomes in UBXD8 insertion into ER subdomains, we depleted cells of PEX5, an essential peroxin for import of peroxisomal matrix proteins 30 ( Supplementary  Fig. 5a ). Although these cells lacked mature peroxisomes ( Supplementary Fig. 5b ), no defect in the import of in vitro-translated sUBXD8op after semi-permeabilization was observed, indicating that mature peroxisomes are dispensable for UBXD8 insertion (Fig. 6g ).
PEX19 farnesylation is essential for UBXD8 localization to the ER and LDs
PEX19 is known to be farnesylated in cells but this post-translational modification is dispensable for peroxisome biogenesis 31 . To test whether PEX19 farnesylation affects UBXD8 localization, we overexpressed either PEX19 WT or the farnesylation-deficient mutant PEX19 C296S in wild-type cells and monitored the steadystate localization of endogenous UBXD8 by immunofluorescence (Fig. 7a-c) . Overexpression of either PEX19 WT (Fig. 7a) ( Fig. 7b) did not disrupt the ER distribution of endogenous UBXD8, presumably because endogenous wild-type PEX19 is still present in these cells. Interestingly, however, overexpression of PEX19 WT led to pronounced accumulation of UBXD8 on LDs as revealed by BODIPY co-staining (Fig. 7a) . We previously reported that UBXD8 accumulation on LDs results either from overexpression of UBXD8 or from induction of LD biogenesis by oleate treatment 7 . The observation that PEX19 WT overexpression induces endogenous UBXD8 accumulation on LDs in cells not loaded with oleate suggests that PEX19 is limiting for UBXD8 trafficking to LDs.
In striking contrast, PEX19 C296S overexpression in wild-type cells led to enrichment of UBXD8 in punctate structures that did not correlate with LDs (Fig. 7b) , but co-localized with the peroxisome marker PMP70 (Fig. 7c) . This dominant-negative effect of overexpressed PEX19 C296S on UBXD8 distribution in wild-type cells suggests that PEX19 farnesylation is essential to prevent delivery of UBXD8 to peroxisomes and to promote partitioning to ER sites from where it can be mobilized to LDs. Indeed, while stable expression of PEX19 C296S rescued peroxisome biogenesis in PEX19 −/− cells (Fig. 7d-f and Supplementary Fig. 6 ), it failed to complement PEX19 function on the localization of endogenous UBXD8, which remained mislocalized to mitochondria as in PEX19 −/− cells (Fig. 7e,f) . Moreover, a fraction of endogenous UBXD8 in PEX19 −/− PEX19 C296S cells was also present on peroxisomes (Fig. 7f) , reflecting the profound mistargeting of UBXD8 Fifty-seven sUBXD8 FL op foci were analysed. The grey-shaded bar indicates the percentage of sUBXD8 FL op foci that co-localized with PEX3 foci and were also found to be adjacent to sUBXD8 FL op-negative PEX3 foci within a distance of 50-250 nm. (g) Insertion of UBXD8 into ER foci is independent of mature peroxisomes. WT cells were transfected with indicated siRNAs for 120 h, used for semi-permeabilization and import of sUBXD8 FL op, and stained with anti-opsin or anti-catalase antibodies as indicated. Scale bars, 10 µm. Representative images from a single experiment are shown. The experiment in a was repeated four times, in b,d,f, once, and in g twice, with similar results.
to peroxisomes after PEX19 C296S overexpression in wild-type cells (Fig. 7b,c) . Additionally, we found that the amount of endogenous UBXD8 on LDs isolated from oleate-treated PEX19 −/− PEX19 C296S cells was strongly (∼70%) reduced compared with wild-type cells (Fig. 7g,h ). Together, these findings demonstrate an essential role for PEX19 farnesylation in directing UBXD8 to ER and LD membranes. 
DISCUSSION
Post-translational protein integration into membranes implies that biosynthesis on cytosolic ribosomes is mechanistically uncoupled from membrane insertion and raises the question of how organellespecific UBXD8 targeting within a cellular context is achieved. Selective targeting requires favoured delivery to the correct target membrane and prevention of promiscuous integration into inappropriate membranes. In this study we identified PEX19 and BAG6 as direct HP-domain-specific binding partners of newly synthesized UBXD8 and provide three lines of evidence supporting the conclusion that PEX19 specifies correct targeting of UBXD8 to ER membranes in cells. First, misdirecting PEX19 to the nucleus leads to nuclear accumulation of UBXD8. Second, in the absence of PEX19, endogenous UBXD8 is mislocalized to mitochondria, consistent with our observation that UBXD8 can insert into protein-free membranes and with studies showing that other post-translationally inserted membrane proteins can accumulate in mitochondrial membranes when their respective organelle-targeting pathways are disrupted [32] [33] [34] . Third, blocking PEX19 function with a soluble fragment of PEX3 in semi-intact cell import-assays prevents insertion of in vitro-synthesized UBXD8 into ER subdomains and also causes mitochondrial mislocalization.
The role for BAG6 in UBXD8 biogenesis is less clear. This multifunctional chaperone has been implicated in a variety of cellular processes including ER-membrane targeting, protein quality control, and ER-associated protein degradation 14, [35] [36] [37] . BAG6 could contribute to UBXD8 targeting independently of or in collaboration with PEX19, or alternatively, could participate in UBXD8 turnover ( Supplementary  Fig. 7 ). Further investigation is required to assess these possibilities.
PEX19 and PEX3 are essential for de novo peroxisome biogenesis at the ER and for post-translational insertion of PMPs into peroxisomal membranes 30, 38 . PEX3 can be biosynthetically inserted into the ER [25] [26] [27] , where it concentrates in a discrete subdomain termed the preperoxisomal ER (pER) 28, 29 . Pre-peroxisomal vesicles bud from the pER in a process dependent on the interaction of PEX3 with PEX19 24, 39, 40 , and a PEX3 function in intra-ER sorting and packaging of PMPs has been suggested 40 . Our finding that newly synthesized UBXD8 inserts into PEX3-containing ER subdomains leads us to speculate that the pER may have a more general role; perhaps as an ER domain specialized for sorting of membrane proteins that are targeted to the ER by non-canonical insertion pathways. Our data establish that PEX19 farnesylation, which is dispensable for peroxisome biogenesis 31 , is essential for UBXD8 insertion into the ER and LD partitioning. It may therefore serve to segregate HP-anchored proteins destined for LDs from bilayer-spanning peroxisomal proteins. Further studies will reveal whether and how this covalent lipid modification influences the association of PEX19 with PEX3-containing ER subdomains.
LDs and peroxisomes both originate from the ER membrane and have complementary roles in lipid metabolism 41 . LDs store neutral lipids and hydrolyse them into fatty acids, which are further metabolized in peroxisomes. Conversely, peroxisomes uniquely synthesize ether lipids, which account for up to 20% of the neutral lipid content of LDs and are absent from LDs in cells lacking peroxisomes 42, 43 . LDs and peroxisomes are spatially associated and their juxtaposition with the ER 44 suggests that all three organelles are intimately coupled to balance lipid storage and consumption. Our finding that peroxisomal proteins and LD-destined HP proteins share targeting machinery raises the hypothesis that LD and peroxisome biogenesis may be mechanistically coordinated in the ER. We previously reported that UBXD8 positively regulates LD abundance by controlling the activity of the major lipase on LDs 7 . Thus, coordinating the biogenesis of such a protein with peroxisome biogenesis could allow mutual control of metabolic functions fulfilled by these organelles that have to act in concert during metabolic change.
METHODS
Methods, including statements of data availability and any associated accession codes and references, are available in the online version of this paper.
Note: Supplementary Information is available in the online version of the paper DOI: 10.1038/ncb3373
Reagents.
Canine pancreas rough microsomes were a gift from B. Dobberstein and stored at 2 eq µl −1 in RM buffer (250 mM sucrose, 50 mM Hepes/KOH pH 7.6, 50 mM KOAc, 2 mM Mg(OAc) 2 , 1 mM dithiothreitol (DTT)). Purified WRBcc and MBP was a kind gift from F. Vilardi and have been described earlier 12 .
Plasmids and antibodies. Expression constructs for RAMP4op and Ctb5op were a gift from B. Dobberstein and are described elsewhere 10 . UBXD8 constructs used in this study are derived from previously published UBXD8 expression plasmids 7 that were used as templates for PCR-based cloning using primers encoding either an s-tag (MKETAAAKFERQHMDS) or an opsin-tag (GPNFYVPFSNKTG) as well as either an XbaI or a NotI restriction site. PCR products were digested with the indicated enzymes and ligated into an empty pCDNA3.1(-) vector cut with the same enzymes. UBXD8 constructs lacking internal amino-acid sequences ( HP, 53-90, 53-111) were generated by primer-extension overlap PCR. Following digestion of the parental plasmid DNA by DpnI, the PCR reaction was transformed into Escherichia coli DH5alpha, and positive clones were identified by restriction digest/sequencing and then subcloned into an empty pCDNA3.1(-) vector using XbaI and NotI. Similarly, to introduce a PreScission protease cleavage site preceding the C-terminal S-tag in UBXD8 constructs, primers encoding the amino-acid sequence LEVLFQGP were used for primer-extension overlap PCR. pRK5rs-Iiop 45 was used for cloning Iiop into pCDNA3.1(-) by PCR and ligation of the XbaI/NotI fragment. PEX19 expression constructs are derived from a cDNA clone (Thermo clone ID: 2820701) and cloned into pCDNA3.1(-) by generating PCR products with XbaI/NotI restriction sites. The reverse primer used to generate PEX19 C296S encoded the G887C mutation. To generate N-terminally NLS-tagged PEX19, a forward primer encoding the amino-acid sequence MAPKKKRKVGDGS was used. To generate N-terminally hexa-histidine-tagged PEX3 N40 for bacterial expression and purification, we used a PEX3 cDNA (true clone origene SC117821), a forward primer encoding an NcoI restriction site followed by caccaccaccaccaccac encoding six consecutive histidines and complementary to the authentic PEX3 sequence lacking the first 40 amino acids and a reverse primer encoding an NotI restriction site. The PCR product was cloned into a pET21d vector using the indicated enzymes.
All constructs were verified by sequencing and detailed sequence information will be made available on request.
The In vitro transcription/in vitro translation. All mRNAs were generated from PCR products using the RiboMax large-scale RNA production system T7 supplemented with m7G cap analogue (Promega), DNase I digested, and purified using Microspin G-25 columns (GE Healthcare) according to the manufacturer's instructions. Proteins were translated in rabbit reticulocyte lysate (RRL; Promega) supplemented either with complete amino-acid mix or, to synthesize radiolabelled proteins, with amino-acid mix lacking methionine and ( 35 S)-protein labelling mix from Perkin Elmer (11 µCi µl −1 ) for 45 min at 30 • C.
Protein insertion assays into RMs, liposomes and semi-permeabilized cells. For co-translational protein insertion, 0.2 eq µl −1 RMs were present during the in vitro translation reaction, whereas for post-translational insertion RMs were added for 30 min after the translation reaction was stopped by addition of 2.5 mM puromycin. Soluble proteins (fraction S) were separated from membranes by centrifugation (100,000g , 5 min) through a sucrose cushion. Peripheral proteins were released from these membranes with 0.1 M carbonate pH 11.0 (fraction P) and membrane-integral proteins (fraction M) re-isolated by centrifugation (130,000g , 10 min). Proteins from all fractions were precipitated by adding two volumes of saturated ammonium sulfate and analysed by SDS-PAGE and autoradiography.
Liposomes were generated from egg PC (L-α-phosphatidylcholine; Avanti Polar Lipids) in liposome buffer (50 mM Hepes/KOH pH 7.6, 50 mM KOAc, 2 mM Mg(OAc) 2 pH 7.5) to a final concentration of 8 mg ml −1 and an average diameter of 100 nm by extrusion. Texas-Red DHPE (0.5%; Invitrogen) was incorporated to visualize the liposome-containing fractions. Liposomes were post-translationally added to the in vitro translation reaction to a final concentration of 0.8 mg ml −1 PC and incubated for 30 min. For liposome flotation, a 12 µl reaction was mixed with 236 µl liposome buffer containing 50% sucrose, overlaid with 500 µl liposome buffer containing 30% sucrose and 250 µl liposome buffer, and centrifuged in a TLS-55 for 3 h at 162,000g and 4 • C. Four fractions (300, 200, 200, 300 µl) were collected from top to bottom, supplemented with 50 µg insulin as a carrier and proteins precipitated with ammonium sulfate followed by SDS-PAGE and autoradiography.
For protein insertion into semi-permeabilized cells, cells were seeded onto glass coverslips and semi-permeabilized by 0.003% digitonin in S-buffer (250 mM sucrose, 20 mM Hepes/KOH pH 7.4, 2.5 mM Mg(OAc) 2 , 25 mM KCl, 2.5 mM EGTA, 1 mM DTT, protease inhibitors) for 5 min. After washing out the cytosol, in vitro translation reactions were added to the cells post-translationally for 30 min, non-inserted proteins removed by washing in S-buffer and cells fixed with 4% formaldehyde in PBS. Proteins of interest were detected by standard immunofluorescence protocols or samples processed for immuno-electron microscopy.
Pre-treatment of RMs. For trypsin treatment, pelleted RMs were resuspended in 20 µg ml −1 trypsin (Promega, sequencing grade) freshly dissolved in PSB (50 mM Hepes/KOH pH 7.4, 100 mM KOAc, 2 mM Mg(OAc) 2 ) and incubated for 1 h on ice. The reaction was stopped by adding 20 µg ml −1 aprotinin (SIGMA) and 2 mM phenylmethyl sulfonyl fluoride (PMSF) and incubation on ice for 15 min. RMs were collected by centrifugation through a 500 mM sucrose cushion in PSB, washed in aprotinin-and PMSF-containing PSB and re-collected by centrifugation through a sucrose cushion. For NEM treatment, pelleted RMs were resuspended in PSB containing 2 mM NEM and incubated for 30 min at 25 • C. The reaction was quenched with 20 mM DTT and RMs were collected by centrifugation through a 500 mM sucrose cushion in PSB.
In both cases the final RM pellet was resuspended in RM buffer to a final volume equal to the starting material and stored in aliquots at −80 • C after flash freezing. As controls, RMs were treated as outlined above without adding trypsin or NEM, respectively.
Protease-protection assays. After protein insertion into RMs, membranes were resuspended in 50 mM Hepes/KOH pH 7.6, 50 mM KOAc, 2 mM Mg(OAc) 2 and incubated with 2 mg ml −1 Proteinase K (Invitrogen) for 45 min at 30 • C. Digestion was stopped by adding 5 mM PMSF and samples were either directly added to boiling SDS-sample buffer, further fractionated by centrifugation through a sucrose cushion containing 5 mM PMSF (130,000g , 10 min), or subjected to affinity purification after protein denaturation in boiling SDS (1% in Tris/HCl pH 8.0) and 1:10 dilution with 1% Triton X-100, 100 mM NaCl, 50 mM Hepes pH 7.4.
For digestion of proteins inserted into liposomes, proteinase K was added to the in vitro insertion reaction and liposomes were isolated by flotation as described. Proteins in the liposome-containing top fraction were either TCA precipitated in the presence of 0.5% Triton X-100 as a carrier or affinity isolated after solubilization with 1% Triton X-100 in 10 mM Tris/HCl pH 7.5, 150 mM NaCl, 2 mM EDTA. Proteins were analysed by autoradiography after separation on 12% BisTris NuPAGE precast gels with MES buffer (Invitrogen).
Analyses of UBXD8 pre-insertion complexes by S-affinity isolation, chemical crosslinking and sucrose gradient fractionation. S-tagged UBXD8 variants were translated in RRL (40 µl reaction volume) in the absence of membranes, the reaction stopped by addition of 2.5 mM puromycin and diluted with 900 µl PBS. UBXD8 complexes were affinity isolated using S-agarose beads (Novagen). After washing in cleavage buffer (20 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 0.5 mM EDTA), proteins were eluted from the beads by addition of SDS-sample buffer and heating at 65 • C for 10 min. The presence of UBXD8, PEX19 and BAG6 in the purified complexes was assessed by immunoblotting following SDS-PAGE.
For chemical crosslinking, radiolabelled UBXD8 variants were translated in RRL as described above. After diluting the reactions with 10 volumes of PBS, they were incubated with 250 mM BMH crosslinker (Pierce), or dimethylsulfoxide as a negative control, for 30 min at 25 • C. The reactions were quenched with 20 mM DTT, supplemented with 10 mM Tris/HCl pH 7.5 and proteins denatured by adding 1% SDS and heating for 10 min at 55 • C. After diluting the reaction tenfold with IP buffer A (10 mM Tris/HCl pH 7.5, 150 mM NaCl, 2 mM EDTA, 0.4% Triton X-100) proteins were immunoprecipitated. After washing the beads with IP buffer A, IP buffer B (10 mM Tris/HCl pH 7.5, 500 mM NaCl, 2 mM EDTA, 0.2% NP-40) and 10 mM Tris/HCl pH 7.5 proteins were eluted with SDS-sample buffer and incubation at 65 • C for 10 min followed by SDS-PAGE and visualization by autoradiography.
To separate UBXD8 pre-insertion complexes, 100 µl in vitro translation reactions were layered onto 2 ml 5-20% sucrose gradients (in 50 mM Hepes/KOH pH 7.4, 100 mM KOAc, 2 mM MgCl 2 ) and centrifuged for 5 h at 55,000 r.p.m. at 4 • C in a TLS-55 rotor. Ten fractions (200 µl each) were collected from the top, diluted with 900 µl PBS and subjected to S-affinity purification, SDS-PAGE and immunoblotting as described above.
For membrane insertion assays, radiolabelled UBXD8 complexes were separated on sucrose gradients, 100 µl of each fraction supplemented with 8 eq RMs for 30 min at 30 • C, and insertion reactions fractionated into soluble (S), peripheral (P) and membrane-integrated proteins (M). UBXD8 amounts in the individual S and M fractions were quantified by densitometry and relative amounts in the M fraction compared with the sum of S and M calculated. For regression analyses, protein amounts of affinity-isolated UBXD8 and associated PEX19 and BAG6 in the individual sucrose gradient fractions were quantified from a parallel immunoblotting experiment by densitometry and plotted against UBXD8 membrane insertion efficiency.
Cell culture and transfection. HeLa Kyoto cells 47 were cultivated at exponential growth rates in DMEM containing 4.5 g l −1 glucose and glutamine (Corning) supplemented with 10% FCS (Gemini) at 37 • C and 5% CO 2 and regularly tested for the absence of mycoplasma. No cell lines used in this study were found in the database of commonly misidentified cell lines that is maintained by ICLAC and NCBI Biosample. We did not attempt to authenticate our cell lines. Fugene 6 (Promega) was used for transient plasmid transfections and Lipofectamine 2000 (Life Technologies) for transient siRNA transfections according to the manufacturer's instructions. Two individual Silencer Select pre-designed siRNAs specific for PEX3, PEX19 and PEX5, respectively, and a scrambled siRNA control were used at a final concentration of 3.3 nM (Life Technologies; IDs: s16154, s16156, s11612, s11613, s11630, s11632, 4390843). After 4 h of siRNA transfection cells were supplemented with fresh medium. Cells were then either grown for an additional 72 h before further processing (PEX3 and PEX19 knockdown) or 48 h later seeded for a second round of siRNA transfection and processed 120 h after the first transfection (PEX5 knockdown).
For LD induction, cells were treated with 200 µM oleic acid in complex with 0.2% BSA in standard medium for 16 h. To deplete LDs from cells 10 µM triacsin C was added to cells for 16 h.
For generating clonal PEX19 −/− cell lines stably expressing PEX19 C296S , selection medium (DMEM/10% FBS/500 µg ml −1 geneticin) was added to cells 48 h posttransfection. Pools stably expressing PEX19 C296S were seeded for clonal selection after 2 weeks. Single-cell-derived clones were isolated, individually expanded under selection pressure and analysed by immunofluorescence and immunoblotting.
Immunoblotting. For quantitative immunoblotting, cells were collected in PBS, lysed in 1% Triton X-100, 50 mM Hepes pH 7.5, 150 mM NaCl, 10% glycerol, 1 mM EDTA, 1 mM PMSF, Complete EDTA-free protease inhibitors (Roche) for 15 min on ice and samples were cleared by centrifugation (16,000g , 10 min, 4 • C). Protein concentration was determined by BCA assay (Pierce), and equal protein amounts were separated by SDS-PAGE, followed by wet-transfer onto nitrocellulose membranes. Skimmed milk (5%) in TBS-T was used to block nonspecific binding and to dilute antibodies. IRDye secondary antibodies (LiCor) were used for signal detection by Odyssey imaging (LiCor). Band intensities were quantified by densitometry using either ImageJ or Image Studio Lite software (LiCor).
Immunofluorescence. For immunofluorescence, cells were seeded onto glass coverslips (no. 1.5 high precision), fixed with 4% formaldehyde in PBS for 20 min and permeabilized with 0.1% Triton X-100 for 10 min. Nonspecific binding sites were blocked with either 1% BSA or 3% BSA/5% FBS in PBS followed by antibody incubation in the same solution. BODIPY 493/503 (Invitrogen) was used at 5 µg ml −1 to stain LDs. Specimen were mounted on glass slides using Fluoromount G (EMS) or slow fade gold (Invitrogen) and analysed using a Zeiss AxioImager.M1 microscope with PlanApochromat oil objectives (63× or 100×/1.4 N.A.) and appropriate filter sets. Usually eight individual z-sections in 300 nm intervals were collected using a CoolSNAP HQ camera (Photometrics). Where indicated, images were deconvolved using the Slidebook software and the nearest-neighbour setting. Individual data sets were normalized for brightness/contrast and merged, and pseudo-coloured pictures were generated using ImageJ software. Micrographs were cropped and assembled using Adobe Photoshop and Illustrator.
For structured illumination microscopy, specimens were examined with the Deltavision OMX Blaze 3D-SIM microscope equipped with three electronmultiplying CCDs (charge-coupled devices; Photometrics, Evolve 512) and an U-PLANAPO SIM objective (100×/1.42 N.A.). Individual z-sections of 125 nm were taken, reconstructed and aligned using the SoftWoRx software. Parameters for channel alignment were verified on the same day by calibration with fluorescent beads.
For assessment of co-localization, fluorescence intensity profiles were plotted and intensity peak distances measured using ImageJ. All SIM micrographs have a pixel size of 40.35 nm.
Electron microscopy. After protein insertion into semi-permeabilized cells, cells were fixed with 4% formaldehyde/PBS for 20 min, washed in PBS, and quenched with 50 mM glycine/PBS for 5 min. After washing in PBS, nonspecific binding sites were blocked with 3%BSA/5% FBS/PBS for 20 min followed by incubation with anti-opsin antibodies for 1 h. Fluoronanogold, which is a 1.4 nm nanogold particle and Alexa Flour 488 fluorophore coupled to an affinity-purified Fab fragment (Nanoprobes, Cat. 7202) was used as a secondary probe in a 1:300 dilution. Specific labelling of sUBXD8op insertion sites as seen with conventional immunofluorescence was verified by examining a parallel sample by fluorescence microscopy. For ultrastructural characterization, specimens were fixed in 4% PFA/2% glutaraldehyde/0.1 M cacodylate. Gold particles were enhanced for 6 min using GoldEnhance EM Plus (Nanoprobes) followed by post-fixation in 1% OsO 4 for 1 h and en bloc staining with 1% uranyl acetate overnight. After dehydration samples were embedded into Epon resin and 80 nm ultrathin sections were collected on carbon-coated copper grids. Contrasting was performed with a 1:1 mix of 3% uranyl acetate and acetone for 30 s followed by lead citrate staining (0.2%) for 3 min. Specimens were examined with a Joel, JEM1400 transmission electron microscope equipped with a Gatan Orius 10.7 megapixel CCD camera at 120 kV.
Large-scale affinity purification and mass spectrometry of UBXD8 pre-insertion complexes. Large-scale (1 ml) in vitro translation reactions without mRNA or supplemented with mRNAs of opUBXD8 FL PPs or opUBXD8 HP PPs encoding a PreScission protease cleavage site (LEVLFQGP) preceding the C-terminal S-tag were carried out for 45 min at 30 • C and terminated by adding 2.5 mM puromycin. Potential aggregated protein species and ribosomes were removed by centrifugation (260,000g , 30 min) and opUBXD8-PPs complexes were isolated on S-agarose beads. Beads were extensively washed in a spin column format with cleavage buffer (20 mM Tris/HCl pH 7.5, 150 mM NaCl, 1 mM DTT, 0.5 mM EDTA) and incubated in 2 bead volumes of cleavage buffer supplemented with 8 units of PreScission protease (GE Healthcare) for 4 h at 8 • C with shaking. Proteins were eluted from the column by centrifugation (2 min at 200g ) and incubated with glutathione Sepharose beads to retain GST-tagged PreScission protease during a second elution. Proteins in the final eluates were precipitated by TCA and separated by SDS-PAGE. Whole lanes were excised from the gel, cut into pieces and subjected to in-gel tryptic digestion, peptide extraction and subsequent peptide identification by LC-MS/MS.
Expression and purification of recombinant HIS-tagged PEX3 N40. Expression of N-terminally hexa-histidine-tagged PEX3 N40 was induced in E. coli Rosetta (DE3) cells (Novagen) with 1 mM IPTG at an attenuance (D 600 nm ) of 0.5 for 16 h at 18 • C. Cells were pelleted and resuspended in buffer A (20 mM Tris/HCl pH 8.0, 150 mM NaCl, 5% glycerol, 10 mM imidazole) and cells were lysed by adding 0.5 mg ml −1 lysozyme, 1 mM EDTA, 1 mM PMSF, and Complete protease inhibitors (Roche) for 30 min. After addition of 10 mM MgCl 2 and 10 µg ml −1 DNase I, the lysate was cleared by centrifugation (90,000g for 30 min) and loaded onto a HisTrap HP column (GE Healthcare). After washing with 30 column volumes (CV) of buffer A containing 500 mM NaCl and with 20 CVs of buffer A, proteins were eluted with a linear imidazole gradient over 10 CVs using buffer A and buffer B (20 mM Tris/HCl pH 8.0, 150 mM NaCl, 5% glycerol, 500 mM imidazole). Fractions containing PEX3 N40 were subjected to ultrafiltration and buffer exchange to 20 mM Tris/HCl pH 8.0, 150 mM NaCl, 5% glycerol, 1 mM DTT and protein purity of greater than 95% was assessed by SDS-PAGE and Coomassie staining.
Generation of PEX19 knockout cell lines by CRISPR/Cas9-based genome editing. HeLa Kyoto cells lacking endogenous PEX19 were generated by CRISPR/Cas9-mediated genome editing according to ref. 48 and protocols published by the Zhang laboratory (rev20130212 at http://www.genome-engineering.org/crispr). In brief, we used an online CRISPR design tool (http://crispr.mit.edu) to select four individual guide RNA sequences targeting exon 1 or exon 2 of genomic PEX19 and designed the following oligonucleotides accordingly:
PEX19-Exon1-guide1: 5 -caccGTGTCGGGGCCGAAGCGGAC-3 and 5 -aaacGTCCGCTTCGGCCC CGACAC-3 ; PEX19-Exon1-guide2: 5 -caccgTGTCGGGGCCGAAGCGGACA-3 and 5 -aaacTGTCCGCTTCGGC CCCGACAc-3 ; PEX19-Exon1-guide3: 5 -caccgTGAGGAAGGCTGTAGTGTCG-3 and 5 -aaacCGACACTACAGCC TTCCTCAc-3 ; PEX19-Exon2-guide1: 5 -caccGGGCCCCAGAAGAGATCGCC-3 and 5 -aaacGGCGATCTCTTCTG GGGCCC-3 ;
Oligonucleotides were phosphorylated, annealed and cloned into pX330 (Addgene) using BbsI. CRISPR constructs were verified by sequencing and transfected into cells using Fugene 6 (Roche). After 48 h, transfected cells were diluted to select clonal cell lines, which were screened for the absence of PEX19 by immunoblotting using anti-PEX19 antibodies (Abcam) and by immunofluorescence using anti-catalase antibodies to verify the absence of peroxisomes. At least two individual clonal cell lines derived from each gRNA were used to verify PEX19-mediated effects on UBXD8 insertion into semi-permeabilized cells and on endogenous UBXD8 localization. Cellular fractionation of lipid droplets. Four sub-confluent 10 cm dishes of oleateloaded cells were collected in ice-cold PBS, resuspended and incubated for 10 min in hypotonic lysis medium (HLM; 20 mM Tris/HCl pH 7.4, 1 mM EDTA) containing 250 mM sucrose and Complete EDTA-free protease inhibitors (Roche), and lysed by passaging ten times through a 25G1/2 needle. The post-nuclear supernatant (5 min, 500g ) was adjusted to a final concentration of 20% sucrose, overlaid with HLM and centrifuged for 1 h at 172,000g and 4 • C in a TLS-55 rotor. The buoyant LD fraction was collected using a tube slicer (Beckman), the cytosolic fraction by pipetting and the membrane-containing pellet washed three times with HLM. Proteins in the LD fraction were solubilized for 20 min in 2% Triton X-100 at 65 • C, precipitated with 10% TCA and washed twice with acetone. Equivalent percentages of cytosolic and membrane fractions were analysed next to TCA-precipitated LD proteins by SDS-PAGE and quantitative immunoblotting.
Statistics and reproducibility.
Uncropped scans of all gels are available in Supplementary Fig. 8 .
Experiments used for statistical quantification were repeated independently three times (n = 3) and normalized to values obtained from WT cells. The mean and the standard error of the mean are shown as bar graphs with error bars.
Micrographs, autoradiographs and immunoblots shown are representative for at least two independent experiments as depicted in the individual figure legends. For assessment of sUBXD8op foci co-localization with endogenous proteins at least 50 foci, as depicted in the individual figure legends, were analysed from a representative single experiment. The experiment itself was repeated at least once. For genomeedited PEX19 −/− cells nine independent clonal cell lines were characterized with similar results. For PEX19 −/− cell lines stably expressing PEX19 C296S three independent clonal cell lines were analysed with similar results.
Data availability. All data supporting the findings of this study are available without undue qualification from the corresponding author on request. figure 3d . Here, UBXD8 complexes were S-affinity purified from individual fractions and analysed by SDS-PAGE and immunoblotting using anti-opsin (UBXD8), -BAG6 and -PEX19 antibodies.
A representative blot from a single experiment is shown, the experiment was repeated once with similar results. b) UBXD8, PEX19 and BAG6 amounts in the individual fractions of (a) were quantified by densitometry and the relative ratios of PEX19/UBXD8 or BAG6/UBXD8 calculated. A.U. arbitrary units. Uncropped scans of all gels are available in Supplementary  Figure 8 . Supplementary Figure Quantification of the distance between sUBXD8 FL op foci and PEX14-positive foci using line profiles of fluorescence intensity as shown in (a). 53 sUBXD8 FL op foci were analysed from one representative cell. The experiment itself was not repeated but independent SIM images were acquired from three individual cells and showed similar results. Greyshaded area indicates sUBXD8 FL op foci that colocalised with PEX14 foci and in addition were found adjacent to sUBXD8 FL op-negative PEX14 foci within a distance of 50-250 nm. 
